Literature DB >> 8166606

Toxicokinetics of soman stereoisomers after subcutaneous administration to atropinized guinea pigs.

A H Due1, H C Trap, J P Langenberg, H P Benschop.   

Abstract

The toxicokinetics of the four stereoisomers of the nerve agent C(+/-)P(+/-)-soman were investigated after subcutaneous administration of a 6 LD50 dose (148 micrograms/kg) to anaesthetized, atropinized, and artificially ventilated guinea pigs. Whereas the relatively nontoxic C(+/-)P(+)-isomers were not detected in blood, the highly toxic C(+/-)P(-)-isomers appeared within 1 min in the general circulation and reached maximum levels of 10-15 ng/ml blood within a period of ca. 7 min. In this absorption phase the blood levels of the C(+)P(-)-isomer lag clearly behind those of the C(-)P(-)-isomer. The blood levels of both C(+/-)P(-)-isomers could be mathematically described using non-linear regression by a three-exponential equation, with one exponential term describing the rapid absorption phase and the other two terms describing distribution and elimination. A comparison with the toxicokinetics of the same isomers upon intravenous administration of the same dose shows that the systemic availability upon subcutaneous administration is in the range of 74-83%. Toxicologically relevant concentrations of the C(+/-)P(-)-isomers prevail almost twice as long after subcutaneous than after intravenous administration. From a toxicokinetic point of view, subcutaneous administration of C(+/-)P(+/-)-soman appears not to be a realistic model for the most relevant route of exposure to C(+/-)P(+/-)-soman in case of chemical warfare, i.e. short term respiratory exposure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8166606     DOI: 10.1007/bf03035709

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  13 in total

Review 1.  Toxicokinetics of soman: species variation and stereospecificity in elimination pathways.

Authors:  H P Benschop; L P De Jong
Journal:  Neurosci Biobehav Rev       Date:  1991       Impact factor: 8.989

2.  Spontaneous and oxime-induced reactivation of acetylcholinesterase inhibited by phosphoramidates.

Authors:  J P Langenberg; L P De Jong; M F Otto; H P Benschop
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

3.  Problems in the therapy of Soman poisoning.

Authors:  O L Wolthuis; F Berends; E Meeter
Journal:  Fundam Appl Toxicol       Date:  1981 Mar-Apr

4.  HI-6 therapy of soman and tabun poisoning in primates and rodents.

Authors:  M G Hamilton; P M Lundy
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

5.  Experience with the intensive care management of organophosphate insecticide poisoning.

Authors:  P W du Toit; F O Müller; W M van Tonder; M J Ungerer
Journal:  S Afr Med J       Date:  1981-08-08

6.  Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates.

Authors:  C A Broomfield; D M Maxwell; R P Solana; C A Castro; A V Finger; D E Lenz
Journal:  J Pharmacol Exp Ther       Date:  1991-11       Impact factor: 4.030

7.  Toxicokinetics of the four stereoisomers of the nerve agent soman in atropinized rats--influence of a soman simulator.

Authors:  H P Benschop; E C Bijleveld; L P De Jong; H J Van der Wiel; H P Van Helden
Journal:  Toxicol Appl Pharmacol       Date:  1987-09-30       Impact factor: 4.219

8.  Stabilization and gas chromatographic analysis of the four stereoisomers of 1,2,2-trimethylpropyl methylphosphonofluoridate (soman) in rat blood.

Authors:  H P Benschop; E C Bijleveld; M F Otto; C E Degenhardt; H P Van Helden; L P De Jong
Journal:  Anal Biochem       Date:  1985-12       Impact factor: 3.365

9.  Effect of pretreatment with CBDP on the toxicokinetics of soman stereoisomers in rats and guinea pigs.

Authors:  A H Due; H C Trap; H J Van Der Wiel; H P Benschop
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

10.  The treatment of Soman poisoning and its perspectives.

Authors:  B Bosković
Journal:  Fundam Appl Toxicol       Date:  1981 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.